Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled Trial of Anterior Temporal Lobectomy Versus Gross Total Resection in Newly-diagnosed Temporal Glioblastoma (ATLAS/NOA-29)

NCT07021339 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT07021339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07021339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled Trial of Anterior Temporal Lobectomy Versus Gross Total Resection in Newly-diagnosed Temporal Glioblastoma (ATLAS/NOA-29)
Lead sponsor
University Hospital, Bonn
Phase
Phase 3
Overall status
Recruiting
Start date
November 28, 2024
Completion date
February 28, 2031
Enrollment
178 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newly-diagnosed glioblastoma, temporal lobe